
    
      This study will estimate the PK and relative BA of oxycodone following single oral 40-mg
      doses of 3 modified PF-00345439 Formulations E, F, and G compared with the reference
      PF-00345439 Formulation A under fed conditions in healthy volunteers in order to aid in
      selection of a final formulation.
    
  